Ftse Mib
33.797,16
0,15%
DAX
17.948,14
0,15%
S&P 500
5.018,39
0,00%
NASDAQ Composite
15.605,48
0,00%
Bitcoin
58.809,66
0,98%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Biosyent Inc (RX) Biosyent Inc (RX) Notizie

RX

Biosyent (RX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:RX
DataOraFonteTitoloSimboloCompagnia
24/08/202302:22PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RXBiosyent Inc
16/03/202112:01PR Newswire (Canada)Combogesic® - First Acetaminophen + Ibuprofen Combination Tablet - Now Available for Canadians with Acute PainTSXV:RXBiosyent Inc
16/03/202112:01PR Newswire (Canada)Combogesic(MD) - le premier comprimé associant l'acétaminophène et l'ibuprofène - maintenant disponible pour les Canadien...TSXV:RXBiosyent Inc
25/05/201619:02PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - RXTSXV:RXBiosyent Inc
25/05/201619:00PR Newswire (Canada)IIROC Trading Resumption - RXTSXV:RXBiosyent Inc
25/05/201618:46PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - RXTSXV:RXBiosyent Inc
25/05/201618:44PR Newswire (Canada)IIROC Trading Halt - RXTSXV:RXBiosyent Inc
23/07/201415:43Marketwired CanadaBioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For New Urgent Care Drug ProductTSXV:RXBiosyent Inc
11/07/201423:15PR Newswire (Canada)S&P Dow Jones Indices Announces Quarterly Review of S&P/TSX Venture Select IndexTSXV:RXBiosyent Inc
11/07/201423:15PR Newswire (Canada)Indices S&P Dow Jones annonce les résultats de l'analyse trimestrielle de l'indice sélect S&P/TSX de croissanceTSXV:RXBiosyent Inc
13/06/201423:12MarketwiredBioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceTSXV:RXBiosyent Inc
12/06/201422:01MarketwiredBioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608%TSXV:RXBiosyent Inc
12/06/201414:00MarketwiredBioSyent Pharma Receives Health Canada Approval to Market New Urgent Care ProductTSXV:RXBiosyent Inc
06/06/201414:16MarketwiredBioSyent Annual General Meeting of Shareholders - June 10, 2014TSXV:RXBiosyent Inc
23/05/201414:00MarketwiredBioSyent to Present at the 2014 Marcum MicroCap Investor ConferenceTSXV:RXBiosyent Inc
21/05/201414:00MarketwiredBioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal SuppositoriesTSXV:RXBiosyent Inc
16/05/201414:00MarketwiredBioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%TSXV:RXBiosyent Inc
12/03/201413:00Marketwired CanadaBioSyent Releases Q4 and Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales I...TSXV:RXBiosyent Inc
12/03/201413:00MarketwiredBioSyent Releases Q4 & Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales Inc...TSXV:RXBiosyent Inc
04/03/201414:00MarketwiredBioSyent Pharma Signs Exclusive Licence & Distribution Agreement for a New Gastrointestinal Health Product Already Approved b...TSXV:RXBiosyent Inc
04/03/201413:00Marketwired CanadaBioSyent Pharma Signs Exclusive Licence and Distribution Agreement for a New Gastrointestinal Health Product Already Approved...TSXV:RXBiosyent Inc
13/02/201414:00MarketwiredBioSyent Named to the 2014 TSX Venture Top 50(R) Ranking-Only TSX Venture Company to Be Recognized as a Top Performer for the...TSXV:RXBiosyent Inc
16/01/201414:00MarketwiredBioSyent Announces Appointment of New DirectorTSXV:RXBiosyent Inc
02/12/201314:00MarketwiredBioSyent to Present at the LD Micro VI Investor ConferenceTSXV:RXBiosyent Inc
21/11/201311:00Marketwired CanadaBioSyent Releases Q3 and Nine Month Results-Nine Month Sales Increase 53% and Profit Before Tax Up 77%TSXV:RXBiosyent Inc
01/10/201314:00Marketwired CanadaBioSyent Pharma Signs Exclusive Licence and Distribution Agreement for a New Women's Health Product Already Approved by Healt...TSXV:RXBiosyent Inc
22/08/201314:00Marketwired CanadaBioSyent Releases Q2 and Six Month Results: Six Month Sales Increase 57% and Profit Before Tax Up 68%TSXV:RXBiosyent Inc
06/06/201314:00Marketwired CanadaBioSyent Pharma Launches New FeraMAX(R) Powder-Water Soluble Polysaccharide-Iron Complex Iron SupplementTSXV:RXBiosyent Inc
04/06/201314:00Marketwired CanadaBioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 Year Revenue Growth Rate of 355%TSXV:RXBiosyent Inc
23/05/201314:00Marketwired CanadaBioSyent Pharma Submits Two New Drugs to Health Canada for Marketing ApprovalTSXV:RXBiosyent Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:RX

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
AMP
Amplifon
BIT
TEN
Tenaris
BIT
BAMI
Banco BPM
BIT
PRY
Prysmian
BIT
A2A
A2A
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network